Home/Filings/4/0001209191-23-021921
4//SEC Filing

Lefebvre Eric 4

Accession 0001209191-23-021921

CIK 0001746473other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 6:02 PM ET

Size

5.3 KB

Accession

0001209191-23-021921

Insider Transaction Report

Form 4
Period: 2023-03-29
Lefebvre Eric
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-03-29+21,874157,031 total
Footnotes (2)
  • [F1]On July 28, 2022, the Reporting Person was granted 87,500 performance-vested stock units, the vesting of which are subject to the achievement of various pre-established performance criteria. On March 29, 2023, the Compensation Committee of the Issuer's Board of Directors certified the achievement of an operational performance criteria, resulting in the vesting of 21,874 shares.
  • [F2]Includes 1,231 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.

Issuer

PLIANT THERAPEUTICS, INC.

CIK 0001746473

Entity typeother

Related Parties

1
  • filerCIK 0001614741

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 6:02 PM ET
Size
5.3 KB